Global Paclitaxel and Docetaxel APIs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 100

Published Date: 25 Jun 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Paclitaxel is a chemotherapy medication used to treat ovarian cancer, esophageal cancer, breast cancer, lung cancer, Kaposi's sarcoma, cervical cancer, and pancreatic cancer. It is administered by intravenous injection. There is also an albumin-bound formulation.

Docetaxel (DTX or DXL) is a chemotherapy medication used to treat a number of types of cancer. This includes breast cancer, head and neck cancer, stomach cancer, prostAate cancer and non-small-cell lung cancer.

According to our (Global Info Research) latest study, the global Paclitaxel and Docetaxel APIs market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Paclitaxel and Docetaxel APIs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Paclitaxel and Docetaxel APIs market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2019-2030
Global Paclitaxel and Docetaxel APIs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2019-2030
Global Paclitaxel and Docetaxel APIs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2019-2030
Global Paclitaxel and Docetaxel APIs market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Paclitaxel and Docetaxel APIs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Paclitaxel and Docetaxel APIs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Phyton Biotech, ScinoPharm, Samyang Biopharm, Indena, Teva API, Guilin Huiang Biochemical Pharmaceutical, Yunnan Hande, Taxus Pharma, Fujian South Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Paclitaxel and Docetaxel APIs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Paclitaxel API
    Docetaxel API

Market segment by Application
    Paclitaxel Injection
    Paclitaxel Liposomes
    Nab-paclitaxel
    Docetaxel Injection

Major players covered
    Phyton Biotech
    ScinoPharm
    Samyang Biopharm
    Indena
    Teva API
    Guilin Huiang Biochemical Pharmaceutical
    Yunnan Hande
    Taxus Pharma
    Fujian South Pharmaceutical

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Paclitaxel and Docetaxel APIs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Paclitaxel and Docetaxel APIs, with price, sales quantity, revenue, and global market share of Paclitaxel and Docetaxel APIs from 2019 to 2024.
Chapter 3, the Paclitaxel and Docetaxel APIs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Paclitaxel and Docetaxel APIs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Paclitaxel and Docetaxel APIs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Paclitaxel and Docetaxel APIs.
Chapter 14 and 15, to describe Paclitaxel and Docetaxel APIs sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Paclitaxel and Docetaxel APIs Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Paclitaxel API
        1.3.3 Docetaxel API
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Paclitaxel and Docetaxel APIs Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Paclitaxel Injection
        1.4.3 Paclitaxel Liposomes
        1.4.4 Nab-paclitaxel
        1.4.5 Docetaxel Injection
    1.5 Global Paclitaxel and Docetaxel APIs Market Size & Forecast
        1.5.1 Global Paclitaxel and Docetaxel APIs Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Paclitaxel and Docetaxel APIs Sales Quantity (2019-2030)
        1.5.3 Global Paclitaxel and Docetaxel APIs Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Phyton Biotech
        2.1.1 Phyton Biotech Details
        2.1.2 Phyton Biotech Major Business
        2.1.3 Phyton Biotech Paclitaxel and Docetaxel APIs Product and Services
        2.1.4 Phyton Biotech Paclitaxel and Docetaxel APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Phyton Biotech Recent Developments/Updates
    2.2 ScinoPharm
        2.2.1 ScinoPharm Details
        2.2.2 ScinoPharm Major Business
        2.2.3 ScinoPharm Paclitaxel and Docetaxel APIs Product and Services
        2.2.4 ScinoPharm Paclitaxel and Docetaxel APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 ScinoPharm Recent Developments/Updates
    2.3 Samyang Biopharm
        2.3.1 Samyang Biopharm Details
        2.3.2 Samyang Biopharm Major Business
        2.3.3 Samyang Biopharm Paclitaxel and Docetaxel APIs Product and Services
        2.3.4 Samyang Biopharm Paclitaxel and Docetaxel APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Samyang Biopharm Recent Developments/Updates
    2.4 Indena
        2.4.1 Indena Details
        2.4.2 Indena Major Business
        2.4.3 Indena Paclitaxel and Docetaxel APIs Product and Services
        2.4.4 Indena Paclitaxel and Docetaxel APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Indena Recent Developments/Updates
    2.5 Teva API
        2.5.1 Teva API Details
        2.5.2 Teva API Major Business
        2.5.3 Teva API Paclitaxel and Docetaxel APIs Product and Services
        2.5.4 Teva API Paclitaxel and Docetaxel APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Teva API Recent Developments/Updates
    2.6 Guilin Huiang Biochemical Pharmaceutical
        2.6.1 Guilin Huiang Biochemical Pharmaceutical Details
        2.6.2 Guilin Huiang Biochemical Pharmaceutical Major Business
        2.6.3 Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Product and Services
        2.6.4 Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Guilin Huiang Biochemical Pharmaceutical Recent Developments/Updates
    2.7 Yunnan Hande
        2.7.1 Yunnan Hande Details
        2.7.2 Yunnan Hande Major Business
        2.7.3 Yunnan Hande Paclitaxel and Docetaxel APIs Product and Services
        2.7.4 Yunnan Hande Paclitaxel and Docetaxel APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Yunnan Hande Recent Developments/Updates
    2.8 Taxus Pharma
        2.8.1 Taxus Pharma Details
        2.8.2 Taxus Pharma Major Business
        2.8.3 Taxus Pharma Paclitaxel and Docetaxel APIs Product and Services
        2.8.4 Taxus Pharma Paclitaxel and Docetaxel APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Taxus Pharma Recent Developments/Updates
    2.9 Fujian South Pharmaceutical
        2.9.1 Fujian South Pharmaceutical Details
        2.9.2 Fujian South Pharmaceutical Major Business
        2.9.3 Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Product and Services
        2.9.4 Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Fujian South Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Paclitaxel and Docetaxel APIs by Manufacturer
    3.1 Global Paclitaxel and Docetaxel APIs Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Paclitaxel and Docetaxel APIs Revenue by Manufacturer (2019-2024)
    3.3 Global Paclitaxel and Docetaxel APIs Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Paclitaxel and Docetaxel APIs by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Paclitaxel and Docetaxel APIs Manufacturer Market Share in 2023
        3.4.3 Top 6 Paclitaxel and Docetaxel APIs Manufacturer Market Share in 2023
    3.5 Paclitaxel and Docetaxel APIs Market: Overall Company Footprint Analysis
        3.5.1 Paclitaxel and Docetaxel APIs Market: Region Footprint
        3.5.2 Paclitaxel and Docetaxel APIs Market: Company Product Type Footprint
        3.5.3 Paclitaxel and Docetaxel APIs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Paclitaxel and Docetaxel APIs Market Size by Region
        4.1.1 Global Paclitaxel and Docetaxel APIs Sales Quantity by Region (2019-2030)
        4.1.2 Global Paclitaxel and Docetaxel APIs Consumption Value by Region (2019-2030)
        4.1.3 Global Paclitaxel and Docetaxel APIs Average Price by Region (2019-2030)
    4.2 North America Paclitaxel and Docetaxel APIs Consumption Value (2019-2030)
    4.3 Europe Paclitaxel and Docetaxel APIs Consumption Value (2019-2030)
    4.4 Asia-Pacific Paclitaxel and Docetaxel APIs Consumption Value (2019-2030)
    4.5 South America Paclitaxel and Docetaxel APIs Consumption Value (2019-2030)
    4.6 Middle East & Africa Paclitaxel and Docetaxel APIs Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2030)
    5.2 Global Paclitaxel and Docetaxel APIs Consumption Value by Type (2019-2030)
    5.3 Global Paclitaxel and Docetaxel APIs Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2030)
    6.2 Global Paclitaxel and Docetaxel APIs Consumption Value by Application (2019-2030)
    6.3 Global Paclitaxel and Docetaxel APIs Average Price by Application (2019-2030)

7 North America
    7.1 North America Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2030)
    7.2 North America Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2030)
    7.3 North America Paclitaxel and Docetaxel APIs Market Size by Country
        7.3.1 North America Paclitaxel and Docetaxel APIs Sales Quantity by Country (2019-2030)
        7.3.2 North America Paclitaxel and Docetaxel APIs Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2030)
    8.2 Europe Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2030)
    8.3 Europe Paclitaxel and Docetaxel APIs Market Size by Country
        8.3.1 Europe Paclitaxel and Docetaxel APIs Sales Quantity by Country (2019-2030)
        8.3.2 Europe Paclitaxel and Docetaxel APIs Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Paclitaxel and Docetaxel APIs Market Size by Region
        9.3.1 Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Paclitaxel and Docetaxel APIs Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2030)
    10.2 South America Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2030)
    10.3 South America Paclitaxel and Docetaxel APIs Market Size by Country
        10.3.1 South America Paclitaxel and Docetaxel APIs Sales Quantity by Country (2019-2030)
        10.3.2 South America Paclitaxel and Docetaxel APIs Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Paclitaxel and Docetaxel APIs Market Size by Country
        11.3.1 Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Paclitaxel and Docetaxel APIs Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Paclitaxel and Docetaxel APIs Market Drivers
    12.2 Paclitaxel and Docetaxel APIs Market Restraints
    12.3 Paclitaxel and Docetaxel APIs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Paclitaxel and Docetaxel APIs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Paclitaxel and Docetaxel APIs
    13.3 Paclitaxel and Docetaxel APIs Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Paclitaxel and Docetaxel APIs Typical Distributors
    14.3 Paclitaxel and Docetaxel APIs Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Paclitaxel and Docetaxel APIs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Paclitaxel and Docetaxel APIs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Phyton Biotech Basic Information, Manufacturing Base and Competitors
 Table 4. Phyton Biotech Major Business
 Table 5. Phyton Biotech Paclitaxel and Docetaxel APIs Product and Services
 Table 6. Phyton Biotech Paclitaxel and Docetaxel APIs Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. Phyton Biotech Recent Developments/Updates
 Table 8. ScinoPharm Basic Information, Manufacturing Base and Competitors
 Table 9. ScinoPharm Major Business
 Table 10. ScinoPharm Paclitaxel and Docetaxel APIs Product and Services
 Table 11. ScinoPharm Paclitaxel and Docetaxel APIs Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. ScinoPharm Recent Developments/Updates
 Table 13. Samyang Biopharm Basic Information, Manufacturing Base and Competitors
 Table 14. Samyang Biopharm Major Business
 Table 15. Samyang Biopharm Paclitaxel and Docetaxel APIs Product and Services
 Table 16. Samyang Biopharm Paclitaxel and Docetaxel APIs Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Samyang Biopharm Recent Developments/Updates
 Table 18. Indena Basic Information, Manufacturing Base and Competitors
 Table 19. Indena Major Business
 Table 20. Indena Paclitaxel and Docetaxel APIs Product and Services
 Table 21. Indena Paclitaxel and Docetaxel APIs Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Indena Recent Developments/Updates
 Table 23. Teva API Basic Information, Manufacturing Base and Competitors
 Table 24. Teva API Major Business
 Table 25. Teva API Paclitaxel and Docetaxel APIs Product and Services
 Table 26. Teva API Paclitaxel and Docetaxel APIs Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Teva API Recent Developments/Updates
 Table 28. Guilin Huiang Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 29. Guilin Huiang Biochemical Pharmaceutical Major Business
 Table 30. Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Product and Services
 Table 31. Guilin Huiang Biochemical Pharmaceutical Paclitaxel and Docetaxel APIs Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Guilin Huiang Biochemical Pharmaceutical Recent Developments/Updates
 Table 33. Yunnan Hande Basic Information, Manufacturing Base and Competitors
 Table 34. Yunnan Hande Major Business
 Table 35. Yunnan Hande Paclitaxel and Docetaxel APIs Product and Services
 Table 36. Yunnan Hande Paclitaxel and Docetaxel APIs Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Yunnan Hande Recent Developments/Updates
 Table 38. Taxus Pharma Basic Information, Manufacturing Base and Competitors
 Table 39. Taxus Pharma Major Business
 Table 40. Taxus Pharma Paclitaxel and Docetaxel APIs Product and Services
 Table 41. Taxus Pharma Paclitaxel and Docetaxel APIs Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. Taxus Pharma Recent Developments/Updates
 Table 43. Fujian South Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 44. Fujian South Pharmaceutical Major Business
 Table 45. Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Product and Services
 Table 46. Fujian South Pharmaceutical Paclitaxel and Docetaxel APIs Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. Fujian South Pharmaceutical Recent Developments/Updates
 Table 48. Global Paclitaxel and Docetaxel APIs Sales Quantity by Manufacturer (2019-2024) & (Kg)
 Table 49. Global Paclitaxel and Docetaxel APIs Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 50. Global Paclitaxel and Docetaxel APIs Average Price by Manufacturer (2019-2024) & (US$/Kg)
 Table 51. Market Position of Manufacturers in Paclitaxel and Docetaxel APIs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 52. Head Office and Paclitaxel and Docetaxel APIs Production Site of Key Manufacturer
 Table 53. Paclitaxel and Docetaxel APIs Market: Company Product Type Footprint
 Table 54. Paclitaxel and Docetaxel APIs Market: Company Product Application Footprint
 Table 55. Paclitaxel and Docetaxel APIs New Market Entrants and Barriers to Market Entry
 Table 56. Paclitaxel and Docetaxel APIs Mergers, Acquisition, Agreements, and Collaborations
 Table 57. Global Paclitaxel and Docetaxel APIs Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 58. Global Paclitaxel and Docetaxel APIs Sales Quantity by Region (2019-2024) & (Kg)
 Table 59. Global Paclitaxel and Docetaxel APIs Sales Quantity by Region (2025-2030) & (Kg)
 Table 60. Global Paclitaxel and Docetaxel APIs Consumption Value by Region (2019-2024) & (USD Million)
 Table 61. Global Paclitaxel and Docetaxel APIs Consumption Value by Region (2025-2030) & (USD Million)
 Table 62. Global Paclitaxel and Docetaxel APIs Average Price by Region (2019-2024) & (US$/Kg)
 Table 63. Global Paclitaxel and Docetaxel APIs Average Price by Region (2025-2030) & (US$/Kg)
 Table 64. Global Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2024) & (Kg)
 Table 65. Global Paclitaxel and Docetaxel APIs Sales Quantity by Type (2025-2030) & (Kg)
 Table 66. Global Paclitaxel and Docetaxel APIs Consumption Value by Type (2019-2024) & (USD Million)
 Table 67. Global Paclitaxel and Docetaxel APIs Consumption Value by Type (2025-2030) & (USD Million)
 Table 68. Global Paclitaxel and Docetaxel APIs Average Price by Type (2019-2024) & (US$/Kg)
 Table 69. Global Paclitaxel and Docetaxel APIs Average Price by Type (2025-2030) & (US$/Kg)
 Table 70. Global Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2024) & (Kg)
 Table 71. Global Paclitaxel and Docetaxel APIs Sales Quantity by Application (2025-2030) & (Kg)
 Table 72. Global Paclitaxel and Docetaxel APIs Consumption Value by Application (2019-2024) & (USD Million)
 Table 73. Global Paclitaxel and Docetaxel APIs Consumption Value by Application (2025-2030) & (USD Million)
 Table 74. Global Paclitaxel and Docetaxel APIs Average Price by Application (2019-2024) & (US$/Kg)
 Table 75. Global Paclitaxel and Docetaxel APIs Average Price by Application (2025-2030) & (US$/Kg)
 Table 76. North America Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2024) & (Kg)
 Table 77. North America Paclitaxel and Docetaxel APIs Sales Quantity by Type (2025-2030) & (Kg)
 Table 78. North America Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2024) & (Kg)
 Table 79. North America Paclitaxel and Docetaxel APIs Sales Quantity by Application (2025-2030) & (Kg)
 Table 80. North America Paclitaxel and Docetaxel APIs Sales Quantity by Country (2019-2024) & (Kg)
 Table 81. North America Paclitaxel and Docetaxel APIs Sales Quantity by Country (2025-2030) & (Kg)
 Table 82. North America Paclitaxel and Docetaxel APIs Consumption Value by Country (2019-2024) & (USD Million)
 Table 83. North America Paclitaxel and Docetaxel APIs Consumption Value by Country (2025-2030) & (USD Million)
 Table 84. Europe Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2024) & (Kg)
 Table 85. Europe Paclitaxel and Docetaxel APIs Sales Quantity by Type (2025-2030) & (Kg)
 Table 86. Europe Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2024) & (Kg)
 Table 87. Europe Paclitaxel and Docetaxel APIs Sales Quantity by Application (2025-2030) & (Kg)
 Table 88. Europe Paclitaxel and Docetaxel APIs Sales Quantity by Country (2019-2024) & (Kg)
 Table 89. Europe Paclitaxel and Docetaxel APIs Sales Quantity by Country (2025-2030) & (Kg)
 Table 90. Europe Paclitaxel and Docetaxel APIs Consumption Value by Country (2019-2024) & (USD Million)
 Table 91. Europe Paclitaxel and Docetaxel APIs Consumption Value by Country (2025-2030) & (USD Million)
 Table 92. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2024) & (Kg)
 Table 93. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity by Type (2025-2030) & (Kg)
 Table 94. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2024) & (Kg)
 Table 95. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity by Application (2025-2030) & (Kg)
 Table 96. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity by Region (2019-2024) & (Kg)
 Table 97. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity by Region (2025-2030) & (Kg)
 Table 98. Asia-Pacific Paclitaxel and Docetaxel APIs Consumption Value by Region (2019-2024) & (USD Million)
 Table 99. Asia-Pacific Paclitaxel and Docetaxel APIs Consumption Value by Region (2025-2030) & (USD Million)
 Table 100. South America Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2024) & (Kg)
 Table 101. South America Paclitaxel and Docetaxel APIs Sales Quantity by Type (2025-2030) & (Kg)
 Table 102. South America Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2024) & (Kg)
 Table 103. South America Paclitaxel and Docetaxel APIs Sales Quantity by Application (2025-2030) & (Kg)
 Table 104. South America Paclitaxel and Docetaxel APIs Sales Quantity by Country (2019-2024) & (Kg)
 Table 105. South America Paclitaxel and Docetaxel APIs Sales Quantity by Country (2025-2030) & (Kg)
 Table 106. South America Paclitaxel and Docetaxel APIs Consumption Value by Country (2019-2024) & (USD Million)
 Table 107. South America Paclitaxel and Docetaxel APIs Consumption Value by Country (2025-2030) & (USD Million)
 Table 108. Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity by Type (2019-2024) & (Kg)
 Table 109. Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity by Type (2025-2030) & (Kg)
 Table 110. Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity by Application (2019-2024) & (Kg)
 Table 111. Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity by Application (2025-2030) & (Kg)
 Table 112. Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity by Country (2019-2024) & (Kg)
 Table 113. Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity by Country (2025-2030) & (Kg)
 Table 114. Middle East & Africa Paclitaxel and Docetaxel APIs Consumption Value by Country (2019-2024) & (USD Million)
 Table 115. Middle East & Africa Paclitaxel and Docetaxel APIs Consumption Value by Country (2025-2030) & (USD Million)
 Table 116. Paclitaxel and Docetaxel APIs Raw Material
 Table 117. Key Manufacturers of Paclitaxel and Docetaxel APIs Raw Materials
 Table 118. Paclitaxel and Docetaxel APIs Typical Distributors
 Table 119. Paclitaxel and Docetaxel APIs Typical Customers


List of Figures
 Figure 1. Paclitaxel and Docetaxel APIs Picture
 Figure 2. Global Paclitaxel and Docetaxel APIs Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Paclitaxel and Docetaxel APIs Revenue Market Share by Type in 2023
 Figure 4. Paclitaxel API Examples
 Figure 5. Docetaxel API Examples
 Figure 6. Global Paclitaxel and Docetaxel APIs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Global Paclitaxel and Docetaxel APIs Revenue Market Share by Application in 2023
 Figure 8. Paclitaxel Injection Examples
 Figure 9. Paclitaxel Liposomes Examples
 Figure 10. Nab-paclitaxel Examples
 Figure 11. Docetaxel Injection Examples
 Figure 12. Global Paclitaxel and Docetaxel APIs Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 13. Global Paclitaxel and Docetaxel APIs Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 14. Global Paclitaxel and Docetaxel APIs Sales Quantity (2019-2030) & (Kg)
 Figure 15. Global Paclitaxel and Docetaxel APIs Price (2019-2030) & (US$/Kg)
 Figure 16. Global Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Manufacturer in 2023
 Figure 17. Global Paclitaxel and Docetaxel APIs Revenue Market Share by Manufacturer in 2023
 Figure 18. Producer Shipments of Paclitaxel and Docetaxel APIs by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 19. Top 3 Paclitaxel and Docetaxel APIs Manufacturer (Revenue) Market Share in 2023
 Figure 20. Top 6 Paclitaxel and Docetaxel APIs Manufacturer (Revenue) Market Share in 2023
 Figure 21. Global Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Region (2019-2030)
 Figure 22. Global Paclitaxel and Docetaxel APIs Consumption Value Market Share by Region (2019-2030)
 Figure 23. North America Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 24. Europe Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 25. Asia-Pacific Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 26. South America Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 27. Middle East & Africa Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 28. Global Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Type (2019-2030)
 Figure 29. Global Paclitaxel and Docetaxel APIs Consumption Value Market Share by Type (2019-2030)
 Figure 30. Global Paclitaxel and Docetaxel APIs Average Price by Type (2019-2030) & (US$/Kg)
 Figure 31. Global Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Application (2019-2030)
 Figure 32. Global Paclitaxel and Docetaxel APIs Revenue Market Share by Application (2019-2030)
 Figure 33. Global Paclitaxel and Docetaxel APIs Average Price by Application (2019-2030) & (US$/Kg)
 Figure 34. North America Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Type (2019-2030)
 Figure 35. North America Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Application (2019-2030)
 Figure 36. North America Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Country (2019-2030)
 Figure 37. North America Paclitaxel and Docetaxel APIs Consumption Value Market Share by Country (2019-2030)
 Figure 38. United States Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 39. Canada Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 40. Mexico Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 41. Europe Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Type (2019-2030)
 Figure 42. Europe Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Application (2019-2030)
 Figure 43. Europe Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Country (2019-2030)
 Figure 44. Europe Paclitaxel and Docetaxel APIs Consumption Value Market Share by Country (2019-2030)
 Figure 45. Germany Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 46. France Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 47. United Kingdom Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 48. Russia Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 49. Italy Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 50. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Type (2019-2030)
 Figure 51. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Application (2019-2030)
 Figure 52. Asia-Pacific Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Region (2019-2030)
 Figure 53. Asia-Pacific Paclitaxel and Docetaxel APIs Consumption Value Market Share by Region (2019-2030)
 Figure 54. China Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 55. Japan Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 56. South Korea Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 57. India Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 58. Southeast Asia Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 59. Australia Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 60. South America Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Type (2019-2030)
 Figure 61. South America Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Application (2019-2030)
 Figure 62. South America Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Country (2019-2030)
 Figure 63. South America Paclitaxel and Docetaxel APIs Consumption Value Market Share by Country (2019-2030)
 Figure 64. Brazil Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 65. Argentina Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 66. Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Type (2019-2030)
 Figure 67. Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Application (2019-2030)
 Figure 68. Middle East & Africa Paclitaxel and Docetaxel APIs Sales Quantity Market Share by Country (2019-2030)
 Figure 69. Middle East & Africa Paclitaxel and Docetaxel APIs Consumption Value Market Share by Country (2019-2030)
 Figure 70. Turkey Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 71. Egypt Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 72. Saudi Arabia Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 73. South Africa Paclitaxel and Docetaxel APIs Consumption Value (2019-2030) & (USD Million)
 Figure 74. Paclitaxel and Docetaxel APIs Market Drivers
 Figure 75. Paclitaxel and Docetaxel APIs Market Restraints
 Figure 76. Paclitaxel and Docetaxel APIs Market Trends
 Figure 77. Porters Five Forces Analysis
 Figure 78. Manufacturing Cost Structure Analysis of Paclitaxel and Docetaxel APIs in 2023
 Figure 79. Manufacturing Process Analysis of Paclitaxel and Docetaxel APIs
 Figure 80. Paclitaxel and Docetaxel APIs Industrial Chain
 Figure 81. Sales Channel: Direct to End-User vs Distributors
 Figure 82. Direct Channel Pros & Cons
 Figure 83. Indirect Channel Pros & Cons
 Figure 84. Methodology
 Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Phyton Biotech
ScinoPharm
Samyang Biopharm
Indena
Teva API
Guilin Huiang Biochemical Pharmaceutical
Yunnan Hande
Taxus Pharma
Fujian South Pharmaceutical

Related Reports

Global Paclitaxel and Docetaxel APIs Supply, Demand and Key Producers, 2024-2030

Global Paclitaxel and Docetaxel APIs Supply, Demand and Key Producers, 2024-2030

date 25 Jun 2024

date Pharma & Healthcare

Paclitaxel is a chemotherapy medication used to treat ovarian cancer, esophageal cancer, breast cancer, lung cancer, Kaposi's sarcoma, cervical cancer, and pancreatic cancer. It is administered by intravenous injection. There is also an albumin-bound formulation.

Product Tags

Paclitaxel and Docetaxel APIs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>